Tinodasertib
Star0
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Tinodasertib
- DrugBank Accession Number
- DB18796
- Background
Not Available
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 408.461
Monoisotopic: 408.1586259 - Chemical Formula
- C25H20N4O2
- Synonyms
- 4-{6-[4-(morpholine-4-carbonyl)phenyl]imidazo[1,2- a]pyridin-3-yl}benzonitrile
- Tinodasertib
- External IDs
- AUM 001
- AUM-001
- AUM001
- ETC-206
- ETC1907206
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- MND3WX2R7I
- CAS number
- 1464151-33-4
- InChI Key
- FWRFPHJSGLYXTD-UHFFFAOYSA-N
- InChI
- InChI=1S/C25H20N4O2/c26-15-18-1-3-20(4-2-18)23-16-27-24-10-9-22(17-29(23)24)19-5-7-21(8-6-19)25(30)28-11-13-31-14-12-28/h1-10,16-17H,11-14H2
- IUPAC Name
- SMILES
- O=C(N1CCOCC1)C1=CC=C(C=C1)C1=CN2C(C=C1)=NC=C2C1=CC=C(C=C1)C#N
References
- General References
- Not Available
- External Links
- ChemSpider
- 71046871
- BindingDB
- 375544
- ChEMBL
- CHEMBL4211649
- PDBe Ligand
- X8K
- PDB Entries
- 8p9b
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data2 Recruiting Treatment Metastatic Colorectal Cancer (CRC) 1 somestatus stop reason just information to hide 1 Withdrawn Treatment Chronic Myeloid Leukemia Accelerated Phase (CML-AP, Ph+) / Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+) / Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL) / Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 21, 2024 17:13 / Updated at June 21, 2024 20:33